The analysis showed that the expression of JWA in breast cancer samples (n = 1097) was significantly lower than that in normal samples (n = 114) (http://ualcan.path.uab.edu/analysis.html) (Fig. 1A). Here, ARL6IP5 is linked to breast cancer.